Comparison of Ionsys and Routine Care With Morphine IV (Intravenous) PCA in the Management of Early Post-Operative Mobilisation, Ability to Mobilise and in Time to Fitness For Discharge.

Trial Profile

Comparison of Ionsys and Routine Care With Morphine IV (Intravenous) PCA in the Management of Early Post-Operative Mobilisation, Ability to Mobilise and in Time to Fitness For Discharge.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 08 Jul 2017

At a glance

  • Drugs Fentanyl (Primary) ; Morphine
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms IMPACT
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 30 Dec 2009 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
    • 15 Jul 2009 Actual number of patients (108) added as reported by ClinicalTrials.gov.
    • 10 Jun 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top